Tel Aviv [Israel], December 15 (ANI/Sputnik): The Israel Institute for Biological Research (IIBR) has successfully completed phase one of the domestic coronavirus vaccine trials and plans to start phase two of the clinical trials in the coming days, the Israeli Defense Ministry said on Monday.

"Phase two of clinical trials will begin in the coming days with approximately 1,000 volunteers. The trials will take place at Sheba and Hadassah medical centres, and additional medical centres across the country will gradually join the process," the statement said.

Also Read | South Korea Passes Law to Ban Anti-North Korea Flying Leaflets by Balloon Amid Activists' Outcry.

The continuation of the clinical trials of the COVID-19 vaccine was approved by the country's Ministry of Health after the successful completion of phase one.

"There were no significant side effects during phase one and two expert committees, both internal and external, recommended to start the transition to phase two," the ministry said.

Also Read | First COVID-19 Vaccine Dose in Canada Administered to Healthcare Worker in Toronto.

Phase two of the vaccine trials, which is expected to take several months, will include extensive safety tests with the participation of healthy volunteers aged 18 and over. At this stage, scientists set the task of checking the safety of the vaccine, determining the effective dosage and further evaluating the effectiveness of the drug. The successful completion of phase two will allow the start of the third phase of the vaccine trials involving up to 30,000 volunteers in Israel and abroad. (ANI/Sputnik)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)